Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives
- PMID: 1455898
- DOI: 10.3109/00498259209053137
Role of metabolism and pharmacokinetic studies in the discovery of new drugs--present and future perspectives
Abstract
1. The impact which pharmacokinetics and drug metabolism studies have made to drug discovery programmes is reviewed with examples from the anti-infective, cardiovascular, anti-inflammatory and CNS therapeutic areas. 2. Contributions that advances in analytical technology have made to the early application of pharmacokinetics and drug metabolism are discussed. 3. Some future perspectives are given on the advances being made in basic science and technology and how this will provide the basis for further growth in the contribution to the drug discovery process.
Similar articles
-
Perspectives of pharmacokinetics and metabolism in drug design.Curr Pharm Des. 2009;15(19):2169. doi: 10.2174/138161209788682488. Curr Pharm Des. 2009. PMID: 19601820 No abstract available.
-
Comment. Twenty years on: a review of the current practice of drug metabolism and pharmacokinetic studies in the pharmaceutical industry.Xenobiotica. 1992 Jul;22(7):735-42. doi: 10.3109/00498259209053136. Xenobiotica. 1992. PMID: 1455897 Review. No abstract available.
-
Metabolite identification and profiling in drug design: current practice and future directions.Curr Pharm Des. 2009;15(19):2220-35. doi: 10.2174/138161209788682460. Curr Pharm Des. 2009. PMID: 19601824 Review.
-
The role of pharmacokinetic studies in drug discovery: where are we now, how did we get here and where are we going?Future Med Chem. 2014 Jul;6(11):1233-5. doi: 10.4155/fmc.14.76. Future Med Chem. 2014. PMID: 25162995 No abstract available.
-
Nanosuspensions in drug delivery.Nat Rev Drug Discov. 2004 Sep;3(9):785-96. doi: 10.1038/nrd1494. Nat Rev Drug Discov. 2004. PMID: 15340388 Review.
Cited by
-
Pharmacokinetic considerations in rational drug design.Clin Pharmacokinet. 1994 Mar;26(3):161-8. doi: 10.2165/00003088-199426030-00001. Clin Pharmacokinet. 1994. PMID: 8194280 Review. No abstract available.
-
Design of drugs through a consideration of drug metabolism and pharmacokinetics.Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):193-9. doi: 10.1007/BF03188921. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867661 Review.
-
Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses.J Pharmacokinet Biopharm. 1994 Feb;22(1):41-57. doi: 10.1007/BF02353409. J Pharmacokinet Biopharm. 1994. PMID: 8027948 Review.
-
The influence of food on the absorption and metabolism of drugs: an update.Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):201-11. doi: 10.1007/BF03189714. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8980916 Review.
-
Pharmacokinetic optimization of 4-substituted methoxybenzoyl-aryl-thiazole and 2-aryl-4-benzoyl-imidazole for improving oral bioavailability.Drug Metab Dispos. 2011 Oct;39(10):1833-9. doi: 10.1124/dmd.110.036616. Epub 2011 Jul 8. Drug Metab Dispos. 2011. PMID: 21742898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical